Cell therapy in surgical treatment of fistulas. Preliminary results

Journal Title: Polish Journal of Surgery - Year 2017, Vol 89, Issue 3

Abstract

Risk of recurrence after surgical treatment of a recurrent fistula is up to 50%. It has be known that more aggressive surgical treatment is associated with a high risk of anal sphincter damage and leads to incontinence. Several studies have been designed to elaborate minimally invasive treatment of rectovaginal and anal fistulas. The properties of Adipose-derived Stem Cells (ASC) significantly enhance a natural healing potency. Here, we present our experience with combined surgical and cell therapy in the treatment of fistulas. Materials and Methods: Four patients were enrolled in our study after unsuccessful treatments in the past – patients 1-3 with rectovaginal fistulas including two women after graciloplasty, and patient 4 - a male with complex perianal fistula. Adipose tissue was obtained from subcutaneous tissue. ASCs were isolated, cultured up to 10+/-2 mln cells and injected into the walls of fistulas. Follow-up physical examination and anoscopy were performed at 1, 4, 8, and 12 weeks, 6 and 12 months after implantation. Results: Up to 8 weeks after ASC implantation, symptoms of fistulas’ tracts disappeared. At 8 weeks, in patients 1-3, communication between vaginal and rectal openings was closed and at 12-16 w. intestinal continuity was restored in patient 3 and 4. After a 6-month follow-up, the fistula tract of patient 4 was closed. Up to 12 m. after ASC implantation no recurrences or adverse events were observed. Conclusion: ASCs combined with surgical pre-treated fistula tracts were used in four patients. All of them were healed. This encouraging result needs further trials to evaluate the clinical efficiency and the cost-effectiveness ratio.<br/><br/>

Authors and Affiliations

Marcin Piejko, Michał Romaniszyn, Julia Borowczyk-Michałowska, Justyna Drukała, Piotr Wałęga

Keywords

Related Articles

Short and Long-Term Outcomes After Primary Liver Transplantation in Elderly Patients

The number of elderly patients undergoing liver transplantation (LT) is increasing worldwide. The aim of the study was to evaluate the impact of recipient age exceeding 60 years on early and long-term outcomes after LT....

Zastosowanie śródoperacyjnego neuromonitoringu gałęzi splotu podbrzusznego dolnego w leczeniu chirurgicznym raka odbytnicy – doniesienie wstępne

Cel: Celem pracy jest przedstawienie własnych, wstępnych doświadczeń z zastosowaniem techniki śródoperacyjnego neuromonitoringu w trakcie wycięcia odbytnicy. Materiał i metody: Do zabiegu ze śródoperacyjnym neuromonitori...

Multiple colon perforation as a fatal complication during treatment of metastatic melanoma with ipilimumab – case report

Ipilimumab, an anticancer drug, is an anti-CTLA4 monoclonal antibody. It is used in treatment of disseminated melanoma. Therapy is associated with high risk of complications. One of the most serious, although one of the...

Anastomotic aneurysms- 20-years of experience from one center

Anastomotic aneurysms may develop after any type of vascular surgery, in different areas of the arterial system, and require reoperation. The frequency of occurrence of the above-mentioned is estimated at 1-5%. Material...

Download PDF file
  • EP ID EP189643
  • DOI 10.5604/01.3001.0010.1019
  • Views 84
  • Downloads 0

How To Cite

Marcin Piejko, Michał Romaniszyn, Julia Borowczyk-Michałowska, Justyna Drukała, Piotr Wałęga (2017). Cell therapy in surgical treatment of fistulas. Preliminary results. Polish Journal of Surgery, 89(3), 48-51. https://europub.co.uk/articles/-A-189643